US OptionsDetailed Quotes
NVO240802C137000
- 0.11
- +0.02+22.22%
15min DelayTrading Jul 29 12:32 ET
0.20High0.11Low
0.20Open0.09Pre Close11 Volume188 Open Interest137.00Strike Price181.00Turnover33.39%IV7.12%PremiumAug 2, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type0.0328Delta0.0155Gamma1347.37Leverage Ratio-0.0332Theta0.0005Rho44.15Eff Leverage0.0104Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$Coinbase(COIN.US$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA(NVDA.US$ , $Broadcom(AVGO.US$ , $Qualcomm(QCOM.US$ , and $Micron Technology(MU.US$ all posting gains exceeding 2%. This movement came as the sector attempted to r...
Gapping up
$Coinbase(COIN.US$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA(NVDA.US$ , $Broadcom(AVGO.US$ , $Qualcomm(QCOM.US$ , and $Micron Technology(MU.US$ all posting gains exceeding 2%. This movement came as the sector attempted to r...
37
3
Shares of Viking Therapeutics soared nearly 40% intraday following discussions with the FDA that accelerated the development of their weight loss candidate VK2735 to phase 3 trials, potentially advancing its market debut by a year. This drug, administered monthly, is anticipated to be more convenient than Eli Lilly and Novo Nordisk's treatments. The oral version of VK2735 will be...
1
Following President Biden's announcement of withdrawal from the presidential race, stocks expected to benefit from a "Democratic victory," such as renewable energy, solar companies, electric vehicle manufacturers, and cannabis stocks, began to rise. Meanwhile, "Trump trades" like oil and gas, financials, and healthcare stocks began to cool. Analysts suggest that if Harris becomes president, she may adopt more ag...
4
$ROCHE HOLDING AG(RHHBY.US$
📣 Roche News Snippet:
» CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%)
» data supports once-daily oral dosing regimen
» Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Did you see today's sell-off? 🔴
$Eli Lilly and Co(LLY.US$ $Novo-Nordisk A/S(NVO.US$ $Structure Therapeutics(GPCR.US$ $Viking Therapeutics(VKTX.US$ $Lipocine(LPCN.US$
📣 Roche News Snippet:
» CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%)
» data supports once-daily oral dosing regimen
» Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Did you see today's sell-off? 🔴
$Eli Lilly and Co(LLY.US$ $Novo-Nordisk A/S(NVO.US$ $Structure Therapeutics(GPCR.US$ $Viking Therapeutics(VKTX.US$ $Lipocine(LPCN.US$
5
Chip tensions
Global chip stocks tumbled amid potentially tighter restrictions on U.S. exports to China and escalating geopolitical tensions. U.S.-listed shares of ASML and Taiwan Semiconductor Manufacturing Co plunged 12% and 8%, respectively. The declines followed a Bloomberg report that the Biden administration is weighing tougher restrictions on companies exporting technology to China.
Nvidia shares slumped more than 6%, while Arm Holdings, Lam Research, Applied M...
Global chip stocks tumbled amid potentially tighter restrictions on U.S. exports to China and escalating geopolitical tensions. U.S.-listed shares of ASML and Taiwan Semiconductor Manufacturing Co plunged 12% and 8%, respectively. The declines followed a Bloomberg report that the Biden administration is weighing tougher restrictions on companies exporting technology to China.
Nvidia shares slumped more than 6%, while Arm Holdings, Lam Research, Applied M...
5
1
$Novo-Nordisk A/S(NVO.US$ Novo Nordisk receives Complete Response Letter in the US for Thomson Reuters (11/07/2024) Bagsværd, Denmark, 10 July 2024 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued a Complete
Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufac...
Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufac...
2
No comment yet
Mon Thu : Bank king I account RHB
Supermengg :
104804582 Mon Thu : https://www.moomoo.com/community/feed/112852755415045?share_code=01aXJl